Sam Brusco, Associate Editor06.01.21
GTCR-backed Resonetics has completed an acquisition of Distal Solutions. The Westborough, Mass.-based firm designs and develops of catheter-based delivery systems for interventional medical devices and implants. Distal's founder David Rezac will lead Resonetics' design and development efforts as well as further expansion in the California market.
Distal Solutions is Resonetics’ sixth add-on acquisition since February 2018. The acquisition furthers the company's strategy to build a market leader in precision micro-manufacturing and design of complex interventional medical devices and componentry. By adding Distal's design and development capabilities, Resonetics aims to further accelerate product development cycles.
Chip Hance, Executive Chairman of Resonetics, commented to the press, "Consistent with our initial investment thesis for Resonetics, the acquisition of Distal Solutions strategically enhances Resonetics' capabilities, and further establishes the company's position as a leading service provider to interventional medical device companies."
Sean Cunningham, Managing Director at GTCR, added, "We have great respect for what David and the Distal team has built, and we look forward to our partnership with them. This represents Resonetics' sixth acquisition since our initial investment, and we expect to continue to aggressively pursue tuck-in acquisitions as well as more transformative opportunities."
Distal Solutions is Resonetics’ sixth add-on acquisition since February 2018. The acquisition furthers the company's strategy to build a market leader in precision micro-manufacturing and design of complex interventional medical devices and componentry. By adding Distal's design and development capabilities, Resonetics aims to further accelerate product development cycles.
Chip Hance, Executive Chairman of Resonetics, commented to the press, "Consistent with our initial investment thesis for Resonetics, the acquisition of Distal Solutions strategically enhances Resonetics' capabilities, and further establishes the company's position as a leading service provider to interventional medical device companies."
Sean Cunningham, Managing Director at GTCR, added, "We have great respect for what David and the Distal team has built, and we look forward to our partnership with them. This represents Resonetics' sixth acquisition since our initial investment, and we expect to continue to aggressively pursue tuck-in acquisitions as well as more transformative opportunities."
